Antimalarial drugs reduce cytoadherence and rosetting of Plasmodium falciparum

Journal of Infectious Diseases

Volumn 173, Issue 3, 1996, Pages 691-698

  Udomsangpetch, R ^b   Pipitaporn, B ^b   Krishna, S ^b   Angus, B ^b   Pukrittayakamee, S ^b   Bates, I ^b   Suputtamongkol, Y ^b   Kyle, D E ^b   White, N J ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER; ARTESUNATE; HALOFANTRINE; MEFLOQUINE; QUININE SULFATE; TETRACYCLINE;

ADOLESCENT; ADULT; ANTIMALARIAL ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG POTENCY; ENDOTHELIUM CELL; ERYTHROCYTE ADHESIVENESS; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; ORAL DRUG ADMINISTRATION; PARASITEMIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; ROSETTE FORMATION;

EID: 0030062755     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.3.691     Document Type: Article

References (5)

1. Bruce-Chwatt LJ, ed. Chemotherapy of malaria. 2nd ed. Geneva: World Health Organization (monograph series 27), 1981.
2. White NJ, Krishna S. The treatment of malaria: some considerations and limitations of the current methods of assessment. Trans R Soc Trop Med Hyg 1989;83:767-77.
3. Webster HK, Boudreau EF, Pavanand K, Yongvanitchit K, Pang LW. Antimalarial drug susceptibility testing of Plasmodium falciparum in Thailand using a microdilution radioisotope method. Am J Trop Med Hyg 1985;34:228-35.
4. White NJ, Ho M. The pathophysiology of malaria. Adv Parasitol 1992;31:84-175.
5. Carlson J, Helmby H, Hill AVS, Brewster D, Greenwood BM, Wahlgren M. Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet 1990;336:1457-60.